Klaus Schulze-Osthoff

9PUBLICATIONS
44CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments.

Martin Franck, Katharina John, Monika Rau

|Jun 25, 2025
Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance.

Antonia Kolb, Ana-Marija Kulis-Mandic, Matthias Klein

|Feb 12, 2024
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.

Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko

|Apr 05, 2023
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform.

Daniel Maier, Jörg Janne Vehreschild, Barbara Uhl

|Jul 27, 2021
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment.

Stephanie Busche, Katharina John, Franziska Wandrer

|Oct 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

Anna-Lena Scherr, Andreas Mock, Georg Gdynia

Pageof 2

Frequent Collaborators

2 joint publications

Frank Essmann

2 joint publications

Michael Bitzer

1 joint publications

Philipp J Jost

1 joint publications

Stefan Fröhling